RECURSION PHARMACEUTICALS IN

Ticker: RXRX CUSIP: 75629V104 Class: Common Stock

180 WEALTH ADVISORS, LLC's Holding History (CIK: 0001730817)

Note: Option positions (PUT/CALL) are excluded.

Q4 2025

Shares 93,201 Value ($000) $381 Avg Close $4.95 Range $3.81 - $7.18

Q3 2025

Shares 56,230 Value ($000) $274 Avg Close $5.25 Range $4.45 - $7.15

Q2 2025

Shares 39,430 Value ($000) $200 Avg Close $4.91 Range $3.79 - $6.11

Q1 2025

Shares 28,765 Value ($000) $152 Avg Close $7.29 Range $5.19 - $12.36

Q4 2024

Shares 31,230 Value ($000) $211 Avg Close $6.72 Range $5.60 - $9.55

Q3 2024

Shares 25,775 Value ($000) $170 Avg Close $7.17 Range $5.88 - $8.73

Q2 2024

Shares 17,455 Value ($000) $134 Avg Close $8.72 Range $6.75 - $10.66

Period	Shares	Value ($000)	Average Close	Price Range
Q4 2025	93,201	$381	$4.95	$3.81 - $7.18
Q3 2025	56,230	$274	$5.25	$4.45 - $7.15
Q2 2025	39,430	$200	$4.91	$3.79 - $6.11
Q1 2025	28,765	$152	$7.29	$5.19 - $12.36
Q4 2024	31,230	$211	$6.72	$5.60 - $9.55
Q3 2024	25,775	$170	$7.17	$5.88 - $8.73
Q2 2024	17,455	$134	$8.72	$6.75 - $10.66